December 18, 2013

Helix Announces the Results of Its Annual General and Special Meeting (PDF)

AURORA, ONTARIO–(Marketwired – Dec 18, 2013) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) (“Helix”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, announces that its Annual General and Special Meeting (the “Meeting”) was held today as scheduled.